Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11883476 Canine lyme disease vaccine

Patent 11883476 was granted and assigned to Intervet on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Rhonda LaFleur0

Steven M. Callister0

Mark A. Mogler0

Jennifer C. Dant0

Zhichang Xu0

Date of Patent

January 30, 2024

0

Patent Application Number

167677150

Date Filed

December 3, 2018

0

Patent Citations

US Patent 9441247 TC-83-derived alphavirus vectors, particles and methods

0

US Patent 10983121 Compositions and methods for diagnosing Lyme disease and for predicting Lyme disease spirochete elimination after treatment

0

US Patent 9562079 Vaccines and methods to treat lyme disease in dogs

0

US Patent 6872550 Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens

0

US Patent 8137678 Canine lyme disease vaccine

0

US Patent 8414901 Canine Lyme disease vaccine

0

US Patent 8460913 Promoterless cassettes for expression of alpha virus structural proteins

0

US Patent 9238065 None

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

Patent abstract

The present invention provides a vaccine for canine Lyme disease and methods of making and using the vaccine alone, or in combinations with other protective agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11883476 Canine lyme disease vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool